data13F

NPCE – Neuropace Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares143,233
Combined reported value$2.0M

NPCE chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.01 Added 30.4%143,233$2.0MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 30.4%143,2330.00
Q2 2026Paul Tudor Jones narrow view Reduced 19.0%109,8740.00
Q1 2026Paul Tudor Jones narrow view Reduced 29.8%135,7050.00
Q4 2025Paul Tudor Jones narrow view Added 25.8%193,3460.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 30.4%143,2330.00
Q4 2025Paul Tudor Jones narrow view Added 25.8%193,3460.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view Reduced 19.0%109,8740.00
Q1 2026Paul Tudor Jones narrow view Reduced 29.8%135,7050.00

History

1 peakQ3 2026: 1 tracked investors
Q1 2025: 1 tracked investorsQ2 2025: 1 tracked investorsQ3 2025: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20252026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones143.2K109.9K135.7K193.3K153.7K118.9K48.0K–

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).